Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone845-469-2042
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$17.35 million
Profitability
Miscellaneous
Employees75
Next Earnings DateN/A
OptionableNot Optionable
Repro-Med Systems (OTCMKTS:REPR) Frequently Asked Questions
What is Repro-Med Systems' stock symbol?
Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."
How were Repro-Med Systems' earnings last quarter?
Repro-Med Systems, Inc. (OTCMKTS:REPR) issued its quarterly earnings results on Tuesday, August, 6th. The company reported $0.00 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.02 by $0.02. The business earned $5.35 million during the quarter. Repro-Med Systems had a net margin of 0.17% and a return on equity of 7.63%. View Repro-Med Systems' Earnings History.
What is the consensus analysts' recommendation for Repro-Med Systems?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Repro-Med Systems in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Repro-Med Systems.
Has Repro-Med Systems been receiving favorable news coverage?
News articles about REPR stock have trended very negative recently, InfoTrie reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Repro-Med Systems earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Repro-Med Systems.
Who are some of Repro-Med Systems' key competitors?
Some companies that are related to Repro-Med Systems include Luminex (LMNX), Cryolife (CRY), Axonics Modulation Technologies (AXNX), Intersect ENT (XENT), Orthofix Medical (OFIX), Cerus (CERS), MiMedx Group (MDXG), Orthopediatrics (KIDS), LeMaitre Vascular (LMAT), Anika Therapeutics (ANIK), Antares Pharma (ATRS), SurModics (SRDX), SI-Bone (SIBN), AngioDynamics (ANGO) and Alphatec (ATEC).
What other stocks do shareholders of Repro-Med Systems own?
Who are Repro-Med Systems' key executives?
Repro-Med Systems' management team includes the folowing people:
- Mr. Daniel S. Goldberger, Exec. Chairman (Age 60)
- Mr. Donald B. Pettigrew, CEO, Pres & Chief Commercial Officer (Age 51)
- Ms. Karen Fisher, CFO, Treasurer & Corp. Sec. (Age 53)
- Mr. Manuel A. Marques, Chief Operating Officer (Age 46)
- Mr. Steven Kamphausen, Global VP of Sales & Marketing
Who are Repro-Med Systems' major shareholders?
Repro-Med Systems' stock is owned by many different of retail and institutional investors. Top institutional investors include Parkman Healthcare Partners LLC (1.33%), EAM Investors LLC (0.48%), Essex Investment Management Co. LLC (0.47%), Geode Capital Management LLC (0.28%), Perceptive Advisors LLC (0.19%) and Perceptive Advisors LLC (0.19%). Company insiders that own Repro-Med Systems stock include Arthur J Radin, James M Beck and Joseph M Jr Manko. View Institutional Ownership Trends for Repro-Med Systems.
Which major investors are buying Repro-Med Systems stock?
REPR stock was purchased by a variety of institutional investors in the last quarter, including Parkman Healthcare Partners LLC, EAM Investors LLC, Essex Investment Management Co. LLC, Geode Capital Management LLC, Perceptive Advisors LLC, Perceptive Advisors LLC, Navellier & Associates Inc and Cavalier Investments LLC. Company insiders that have bought Repro-Med Systems stock in the last two years include Arthur J Radin, James M Beck and Joseph M Jr Manko. View Insider Buying and Selling for Repro-Med Systems.
How do I buy shares of Repro-Med Systems?
Shares of REPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Repro-Med Systems' stock price today?
One share of REPR stock can currently be purchased for approximately $7.23.
How big of a company is Repro-Med Systems?
What is Repro-Med Systems' official website?
How can I contact Repro-Med Systems?
Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected]
MarketBeat Community Rating for Repro-Med Systems (OTCMKTS REPR)
| Community Ranking: | | 2.4 out of 5 ( ) |
| Outperform Votes: | | 83 (Thanks for Voting!) |
| Underperform Votes: | | 90 (Thanks for Voting!) |
| Total Votes: | | 173 |
